These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 36176915)
1. Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Ji L; Li Q; He Y; Zhang X; Zhou Z; Gao Y; Fang M; Yu Z; Rodrigues RM; Gao Y; Li M Acta Pharm Sin B; 2022 Sep; 12(9):3529-3547. PubMed ID: 36176915 [TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Dai X; Feng J; Chen Y; Huang S; Shi X; Liu X; Sun Y Chin Med; 2021 Aug; 16(1):68. PubMed ID: 34344394 [TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Han L; Li T; Du M; Chang R; Zhan B; Mao X Nutrients; 2019 Mar; 11(3):. PubMed ID: 30897784 [No Abstract] [Full Text] [Related]
4. Effects of potentilla discolor bunge extracts on oxidative stress and glycolipid metabolism in animal models of diabetes: a systematic review and meta-analysis. Yang Y; Deng W; Wu Y; Zi C; Chen Q Front Pharmacol; 2023; 14():1218757. PubMed ID: 37849729 [No Abstract] [Full Text] [Related]
5. Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. Ding X; He X; Tang B; Lan T Chin Med; 2024 Feb; 19(1):21. PubMed ID: 38310315 [TBL] [Abstract][Full Text] [Related]
6. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular Mechanisms. Ma C; Wang C; Zhang Y; Zhou H; Li Y Curr Mol Pharmacol; 2022; 15(6):846-861. PubMed ID: 34923950 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. Shao G; Liu Y; Lu L; Wang L; Ji G; Xu H J Ethnopharmacol; 2024 Jun; 327():117999. PubMed ID: 38447616 [TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based analysis on bioactive anti-diabetic compounds in Potentilla discolor bunge. Wang N; Zhu F; Shen M; Qiu L; Tang M; Xia H; Chen L; Yuan Y; Ma S; Chen K J Ethnopharmacol; 2019 Sep; 241():111905. PubMed ID: 31022565 [TBL] [Abstract][Full Text] [Related]
9. The water extract of Potentilla discolor Bunge (PDW) ameliorates high-sugar diet-induced type II diabetes model in Drosophila melanogaster via JAK/STAT signaling. Li Y; Wang J; Xu Y; Meng Q; Wu M; Su Y; Miao Y; Wang Y J Ethnopharmacol; 2023 Nov; 316():116760. PubMed ID: 37301307 [TBL] [Abstract][Full Text] [Related]
10. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194 [TBL] [Abstract][Full Text] [Related]
11. Herbal medicines and nonalcoholic fatty liver disease. Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425 [TBL] [Abstract][Full Text] [Related]
12. Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews. Dai L; Zhou WJ; Zhong LLD; Tang XD; Ji G World J Clin Cases; 2021 Jan; 9(1):102-117. PubMed ID: 33511176 [TBL] [Abstract][Full Text] [Related]
13. Water Extract of Li T; Chang R; Zhang H; Du M; Mao X Front Nutr; 2020; 7():161. PubMed ID: 33043040 [No Abstract] [Full Text] [Related]
14. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638 [TBL] [Abstract][Full Text] [Related]
15. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. Liu C; Liao JZ; Li PY World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762 [TBL] [Abstract][Full Text] [Related]
16. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation. Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693 [TBL] [Abstract][Full Text] [Related]
17. Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats. Wu P; Liang S; He Y; Lv R; Yang B; Wang M; Wang C; Li Y; Song X; Sun W Chin Herb Med; 2022 Apr; 14(2):273-282. PubMed ID: 36117665 [TBL] [Abstract][Full Text] [Related]
18. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192 [TBL] [Abstract][Full Text] [Related]
19. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism. Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J Int Immunopharmacol; 2018 Dec; 65():256-267. PubMed ID: 30340105 [TBL] [Abstract][Full Text] [Related]
20. Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease. Li B; Fang L Gastroenterol Res Pract; 2022; 2022():5259088. PubMed ID: 35782337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]